Metraipolis › archive › dc_08027aa03028

Novel pharmacotherapies for opioid use disorder and opioid withdrawal — Europe PMC PMID:42755825

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42755825
DOI: 10.3389/fpsyt.2026.1909149
License (as archived): solo-consultazione
Archived: 2026-10-16T04:40:00.610Z
SHA-256 of the archived text: c8a066e639e04056d6d3d97de8ffaa037fa0047751d9a6e2aaef96b0f5ad2949
Stable URL of this page: https://metraipolis.com/documento/dc_08027aa03028

How to cite

Novel pharmacotherapies for opioid use disorder and opioid withdrawal — Europe PMC PMID:42755825 — Europe PMC (en), https://europepmc.org/article/MED/42755825 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_08027aa03028 (Metraipolis archive dc_08027aa03028, sha256 c8a066e639e04056d6d3d97de8ffaa037fa0047751d9a6e2aaef96b0f5ad2949)

BibTeX

@misc{dc08027aa03028,
  title = {Novel pharmacotherapies for opioid use disorder and opioid withdrawal — Europe PMC PMID:42755825},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42755825},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_08027aa03028; sha256 c8a066e639e04056d6d3d97de8ffaa037fa0047751d9a6e2aaef96b0f5ad2949},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42755825. Agents can read the archived copy with the MCP tool read_document.